SCO administration causes cholinergic dysfunction, upregulation of tau proteins, a decrease in acetylcholine level, increased amyloid beta deposition, and induces cognitive disorders in Alzheimer’s disease [18]. This evidence concerns the gene MAPT and Alzheimer disease.